Spectrum Brands Holdings faces structural concerns despite operational strengths, with sluggish revenue growth and declining sales in key divisions raising red flags for investors. Tariff impacts and ...

Spectrum Pharmaceuticals develops and commercializes cancer therapies, including Rolvedon (formerly eflapegrastim), a long-acting G-CSF for treating chemotherapy-induced neutropenia (CIN). The FDA's ...

ALPHA published a paper in the journal Nature this week that reports the first ever measurement of the optical spectrum of an antimatter atom. The team behind the paper says that this is the result of ...

Scientists report the first ever measurement on the optical spectrum of an antimatter atom. This achievement features technological developments that open up a completely new era in high-precision ...